Close

UBS Maintains a 'Buy' on Par Pharmaceutical (PRX); Strong Generics Sales; Brands Disappoint May 6, 2011 01:44PM
UBS Initiates Coverage on Par Pharmaceutical (PRX) with a Buy; Small and Nimble is Interesting To Us Sep 30, 2010 09:58AM
UBS Starts Alkermes (ALKS), Par Pharma (PRX) at Buy, Salix Pharma (SLXP) at Neutral Sep 30, 2010 07:24AM
Notable Analyst Rating Changes 10/15: JPM, PCG, NVLS, PRX Upgrade; BJS, BHI, SCHW, AZ, TRV, LAZ Downgrade Oct 15, 2009 10:44AM
Notable Analyst Rating Changes 8/19: PRX, ANN, BPOP, AXL, JOYG Upgraded; AA, ANF, TOL, DHI, LUV Downgraded Aug 19, 2009 09:59AM